New Brunswick Drug Chart

The New Brunswick Drug Plan is a prescription drug plan that provides drug coverage for uninsured New Brunswick residents who have an active Medicare card. More information can be found here: https://www2.gnb.ca/content/gnb/en/departments/health/MedicarePrescriptionDrugPlan/NBDrugPlan.html.
 

The drugs covered by the Plan are listed in the New Brunswick drug formulary found here:  https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf.

 

Medication	Benefit Category	Details	Link
Abilify (aripiprazole)	Regular Benefit ....................................	Covered by Plans A, C, D, E, F, G, V	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Abilify Maintena (aripiprazole LAI)	Special Authorization	For the treatment of patients who are: • not adherent to an oral antipsychotic, or • currently receiving a long-acting injectable antipsychotic and require an alternative long-acting injectable antipsychotic.	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Clozaril (clozapine)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Invega (paliperidone)	Not a Benefit		https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Invega Sustenna (paliperidone palmitate)	Special Authorization	For the maintenance treatment of schizophrenia and related psychotic disorders (not dementia related) in patients who: • are not adherent to an oral antipsychotic, or • are currently receiving a long-acting injectable antipsychotic and require an alternative long-acting injectable antipsychotic.	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Invega Trinza (paliperidone palmitate)	Special Authorization	For the maintenance treatment of schizophrenia and related psychotic disorders (not dementia related) in patients who have been stabilized on therapy with injectable paliperidone for at least four months.	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Latuda (lurasidone)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Rexulti (brexpiprazole)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Risperdal (risperidone)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Risperdal Consta (risperidone LAI)	Special Authorization	For the treatment of patients who are: • not adherent to an oral antipsychotic, or • currently receiving a long-acting injectable antipsychotic and require an alternative long-acting injectable antipsychotic.	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Saphris (asenapine)	Special Authorization	For the acute treatment of bipolar I disorder as either: • Monotherapy, after inadequate response to a trial of lithium or divalproex sodium, and there is a history of inadequate response or intolerance to at least one less expensive antipsychotic agent; or • Co-therapy with lithium or divalproex sodium, and there is a history of inadequate response or intolerance to at least one less expensive antipsychotic agent.	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Seroquel (quetiapine)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V, W	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Zeldox (ziprasidone)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Zyprexa (olanzapine)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V, W	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Zyprexa IM (olanzapine IM)	Not a Benefit		https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Clopixol (zuclopenthixol)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V Zuclopenthixol acetate is not a benefit	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Fluanxol (flupentixol)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Modecate (fluphenazine)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Haldol (haloperidol)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V, W	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Largactil (chlorpromazine)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V, W	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Loxapac (loxapine)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V The injectable formulation is not a benefit	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Majeptil (thioproperazine)	Not a Benefit		https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Navane (thiothixene)	Not a Benefit		https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Neuleptil (pericyazine)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Nozinan (methotrimeprazine)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V, W	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Orap (pimozide)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Stelazine (trifluoperazine)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Stemetil (prochlorperazine)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf
Trilafon (perphenazine)	Regular Benefit	Covered by Plans A, C, D, E, F, G, V	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf